Literature DB >> 2143510

Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle.

J Timsit1, B Riou, J Bertherat, C Wisnewsky, N S Kato, A S Weisberg, J Lubetzki, Y Lecarpentier, S Winegrad, J J Mercadier.   

Abstract

We studied papillary muscle mechanics and energetics, myosin phenotype, and ATPase activities in left ventricles from rats bearing a growth hormone (GH)--secreting tumor. 18 wk after tumor induction, animals exhibited a dramatic increase in body weight (+101% vs. controls) but no change in the ventricular weight/body weight ratio. The maximum isometric force of papillary muscles normalized per cross-sectional area rose markedly (+42%, P less than 0.05 vs. controls), whereas the maximum unloaded shortening velocity did not change. This was observed despite a marked isomyosin shift towards V3 (32 +/- 5% vs. 8 +/- 2% in controls, P less than 0.001). Increased curvature of the force-velocity relationship (+64%, P less than 0.05 vs. controls) indicated that the muscles contracted more economically, suggesting the involvement of V3 myosin. Total calcium- and actin-activated myosin ATPase activities assayed on quickly frozen left ventricular sections were similar in tumor-bearing rats and in controls. After alkaline preincubation, these activities only decreased in tumor-bearing rats, demonstrating that V3 enzymatic sites were involved in total ATPase activity. These data demonstrate that chronic GH hypersecretion in the rat leads to a unique pattern of myocardial adaptation which allows the muscle to improve its contractile performance and economy simultaneously, thanks to myosin phenoconversion and an increase in the number of active enzymatic sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143510      PMCID: PMC296753          DOI: 10.1172/JCI114737

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Muscle structure and theories of contraction.

Authors:  A F HUXLEY
Journal:  Prog Biophys Biophys Chem       Date:  1957

2.  Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients.

Authors:  J T Lie
Journal:  Am Heart J       Date:  1980-07       Impact factor: 4.749

3.  The ATPase activities of rat cardiac myosin isoenzymes.

Authors:  B Pope; J F Hoh; A Weeds
Journal:  FEBS Lett       Date:  1980-09-08       Impact factor: 4.124

4.  Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats.

Authors:  G L Engelmann; K D Boehm; J F Haskell; P A Khairallah; J Ilan
Journal:  Mol Cell Endocrinol       Date:  1989-05       Impact factor: 4.102

5.  The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study.

Authors:  L Thuesen; S E Christensen; J Weeke; H Orskov; P Henningsen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-06       Impact factor: 3.478

6.  Beneficial effects of growth hormone treatment in GH-deficient adults.

Authors:  J O Jørgensen; S A Pedersen; L Thuesen; J Jørgensen; T Ingemann-Hansen; N E Skakkebaek; J S Christiansen
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

7.  Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans.

Authors:  Y Fong; M Rosenbaum; K J Tracey; G Raman; D G Hesse; D E Matthews; R L Leibel; J M Gertner; D A Fischman; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Bromocriptine for an acromegalic patient. Improvement in cardiac function and carpal tunnel syndrome.

Authors:  R Luboshitzky; D Barzilai
Journal:  JAMA       Date:  1980-10-17       Impact factor: 56.272

9.  Effect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeletal muscle.

Authors:  R A Prysor-Jones; J S Jenkins
Journal:  J Endocrinol       Date:  1980-04       Impact factor: 4.286

10.  Echocardiographic assessment of cardiac anatomy and function in acromegalic patients.

Authors:  D D Savage; W L Henry; R C Eastman; J S Borer; P Gorden
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  27 in total

1.  The potential for growth hormone in the management of heart failure.

Authors:  J P Monson; G M Besser
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

2.  A physiological basis for variation in the contractile properties of isolated rat heart.

Authors:  L E Lin; G McClellan; A Weisberg; S Winegrad
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

3.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 4.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 5.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

6.  Differential influence of fasting and BM13.907 treatment on growth and phenotype of pressure overloaded rat heart.

Authors:  H Rupp; V Elimban; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Authors:  Peter Kamenicky; Say Viengchareun; Anne Blanchard; Geri Meduri; Philippe Zizzari; Martine Imbert-Teboul; Alain Doucet; Philippe Chanson; Marc Lombès
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

8.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

9.  Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.

Authors:  J Bertherat; J Timsit; M T Bluet-Pajot; J J Mercadier; D Gourdji; C Kordon; J Epelbaum
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.

Authors:  Sjoerd W van Thiel; Jan W A Smit; Albert de Roos; Jeroen J Bax; Ernst E van der Wall; Nienke R Biermasz; Eric Viergever; Hubert W Vliegen; Johannes A Romijn; Ferdinand Roelfsema; Hildo J Lamb
Journal:  Int J Cardiovasc Imaging       Date:  2004-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.